SCHEMBL29601341

SCHEMBL29601341

CC(C)(C)OC(=O)N1CCC(C(=O)O)CC1CN

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ BTK Q06187 1/20 0.43
▸ HPGD P15428 1/20 0.40
▸ RECQL P46063 1/20 0.38
▸ CHRM2 P08172 1/20 0.37
▸ CHRM1 P11229 1/20 0.37
▸ CHRM3 P20309 1/20 0.37
▸ STS P08842 1/20 0.36
▸ PTPN2 P17706 1/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ PTPN6 P29350 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24047701 0.87 HSD17B10 (0.50) HSD17B10SMN1; SMN2BTKHPGDRECQL
SCHEMBL26430589 0.87 HSD17B10 (0.50) HSD17B10SMN1; SMN2BTKHPGDRECQL
SCHEMBL1439128 0.87 HSD17B10 (0.50) HSD17B10SMN1; SMN2BTKHPGDRECQL
SCHEMBL17730541 0.86 HSD17B10 (0.49) HSD17B10SMN1; SMN2BTKHPGDRECQL
SCHEMBL29785811 0.85 HSD17B10 (0.48) HSD17B10SMN1; SMN2BTKHPGDRECQL
SCHEMBL1630474 0.84 HTT (0.43) HSD17B10SMN1; SMN2HPGDCHRM2CHRM1
SCHEMBL1630475 0.84 HTT (0.43) HSD17B10SMN1; SMN2HPGDCHRM2CHRM1
SCHEMBL1398690 0.84 HTT (0.43) HSD17B10SMN1; SMN2HPGDCHRM2CHRM1
SCHEMBL10215607 0.83 CHRM2 (0.39) HSD17B10SMN1; SMN2HPGDCHRM2CHRM1
SCHEMBL297706 0.83 CHRM2 (0.39) HSD17B10SMN1; SMN2HPGDCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4056562-A1 HETEROCYCLIC INHIBITORS OF BRUTON'S TYROSINE KINASE Merck Patent GmbH (DE) 2022-09-14 — — EP disclosed
EP-2718270-B1 COMPOSITIONS AND METHODS FOR THE PRODUCTION OF PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY MERCK PATENT GMBH (DE) 2022-04-27 — — EP disclosed
Send feedback